Absence of KMT2D/MLL2 mutations in abdominal paraganglioma

Clin Endocrinol (Oxf). 2016 Apr;84(4):632-4. doi: 10.1111/cen.12884. Epub 2015 Sep 22.

Adam Stenman¹, Carl C Juhlin^{2

3

4}, Felix Haglund², Taylor C Brown^{3

4}, Victoria E Clark⁵, Fredrika Svahn², Kaya Bilguvar⁶, Gerald Goh^{7

8}, Reju Korah^{3

4}, Richard P Lifton^{6

7

8}, Tobias Carling^{9

10}

¹ Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. adam.stenman@ki.se.
² Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
³ Yale Endocrine Neoplasia Laboratory, Yale School of Medicine, New Haven, CT, USA.
⁴ Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
⁵ Department of Neurosurgery, Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.
⁶ Department of Genetics and Yale Center for Genome Analysis, Yale School of Medicine, New Haven, CT, USA.
⁷ Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
⁸ Howard Hughes Medical Institute, Yale School of Medicine, New Haven, CT, USA.
⁹ Yale Endocrine Neoplasia Laboratory, Yale School of Medicine, New Haven, CT, USA. tobias.carling@yale.edu.
¹⁰ Department of Surgery, Yale School of Medicine, New Haven, CT, USA. tobias.carling@yale.edu.

No abstract available

Publication types